Chemotherapy-Induced Peripheral Neuropathy Symptom Experience Perceived by Patients with Colorectal Cancer

Main Article Content

เพชรไพลิน ชัยชาญ
นงลักษณ์ เมธากาญจนศักดิ์


This descriptive research aimed to study chemotherapy-induced peripheral neuropathy symptom experience among colorectal cancer patients receiving chemotherapy. The theoretical framework was based on the concept of symptom management proposed by Dodd et al. (2001). The subjects consisted of 206 CRC patients receiving chemotherapy at IPD Unit of Srinagarind Hospital, Faculty of Medicine, Khon Kaen University. The instrument used in this research is a questionnaire consisting of general data questionnaires and questionnaire of chemotherapy-induced peripheral neuropathy symptom experiences. The questionnaires were tested for the CVI was 0.91, 0.87 and 0.89 respectively. The reliability of the instrument was 0.85. The data were collected between March and August 2019, and analyzed through descriptive statistics.

The results are as follows. The most five chemotherapy-induced peripheral neuropathy symptoms of these patients were numbness on the fingers or hand, feel like electric shocked when touch cold or cold objects, numbness on the toes or feet, loss of strength in hands, and tingling fingers or hands. The most five severe symptoms were feel like electric shocked when exposed to cold or cold objects, numbness on the fingers or hand, numbness on the toes or feet, loss of strength in hands, and tingling fingers or hands. The most five suffering symptoms were numbness on the toes or feet, numbness on the fingers or hand,  have writing problem,  constipation and aching or burning pain in fingers or hands. The most five disturbing patient’s daily life were numbness on the fingers or hand,  have writing problem, numbness on the toes or feet, feel like electric shocked when exposed to cold or cold objects, and trouble handling small objects.

              Patients responded to the chemotherapy-induced peripheral neuropathy symptoms by responding to cognitive, physical, psychological and behavioral responses. Most of the patients wanted to find the cause and need help from relatives or medical personnel. Some patient’s don’t need help because they received information that was effects from chemotherapy. The patients response to physical symptoms was most of the patients can do daily activities as usual. They can able to socialize normally, can sleep and can go to work as usual. The patients response to psychological symptoms was most of the patients felt that the symptoms caused them to feel frustrated and feeling that the symptoms cause stress and anxiety, there are only a small number of patient who feel that the symptoms cause bad feelings and feeling lower self-esteem. Most patients responding to behavioral symptoms were having changed their behavior including avoiding cold contact, Exercise of hand and finger, more rest, used massage methods and used warm compress or warm water on hands and feet.

Keyword: chemotherapy-induced peripheral neuropathy


Download data is not yet available.

Article Details



1. Kaeorat P, Pakdevong N. Patients ’ Experiences of Ongoing Chemotherapy for Colorectal Cancer. 2015;92–101.
2. Pimbung N, Wattana C, Harnirattisai T. The Effects of a Symptom-management Program on Severity of Symptom and Nutritional Status among Colorectal Cancer Patients Receiving Chemotherapy. 2015;42(November):73–83.
3. Prasertsri N, Teeyapan W, Leaungsomnapa Y, Wamalun C. Nurse ’ s Role in Caring of Chemotherapy-Induced Peripheral Neuropathy Patients. Journal N, Health P. 2015;1-13
4. Padman S, Lee J, Kumar R, Slee M, Hakendorf P, Richards A, et al. Late effects of oxaliplatin-induced peripheral neuropathy (LEON)—cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years. Support Care Cancer. 2014;23(3):861–9.
5. Tofthagen C, Visovsky CM, Hopgood R. Chemotherapy-Induced Peripheral Neuropathy: 2013;17(2).
6. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2014;32(18):1941–67.
7. Smith EML, Beck SL, Cohen J. The Total Neuropathy Score: A Tool for Measuring Chemotherapy-Induced Peripheral Neuropathy. Oncol Nurs Forum [Internet]. 2008;35(1):96–102. Available from:
8. Kautio AL, Haanpää M, Kautiainen H, Leminen A, Kalso E, Saarto T. Oxaliplatin scale and National Cancer Institute-common toxicity criteria in the assessment of chemotherapy-induced peripheral neuropathy. Anticancer Res. 2011;31(10):3493–6.
9. Curcio KR. Instruments for Assessing Chemotherapy-Induced Peripheral Neuropathy: 2016;20(2).
10. Simão DA da S, Murad M, Martins C, Fernandes VC, Captein KM, Teixeira AL. Chemotherapy-induced peripheral neuropathy: review for clinical practice. Rev Dor [Internet]. 2015;16(3):215–20. Available from:
11. Derksen TME, Bours MJL, Mols F, Weijenberg MP, T.M.E. D, M.J.L. B, et al. Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review. Evid Based Complement Alternat Med. 2017;2017:1–14.
12. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies. Eur J Cancer. 2008;44(11):1507–15.
13. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: Prevention and treatment. Clin Pharmacol Ther. 2011;90(3):377–87.
14. Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer. 2017;25(1):195–204.